Literature DB >> 8358515

Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia.

S S Zhan1, K Beyreuther, H P Schmitt.   

Abstract

It has remained a matter of debate until now whether amyloid and tangle pathology may be regarded as the main causes of the dementia in Alzheimer's disease (AD) or only as markers of the disease. In the present study we examined the synaptophysin immunoreactivity of the cortical neuropil as a measure of its synapse density, in 17 cases of AD, 1 case with a 10-month episode of dementia and cortical amyloid deposition, 5 cases of Huntington's disease (HD) with dementia, 11 cases of parkinsonism (PD), 5 with dementia (PD-D) and 16 controls. The immunoreactivity was assessed in two layers (molecular, pyramidal) of three regions (frontal, occipital, hippocampus) by means of automated black-and-white image analysis. In AD we found a rather diffuse reduction of the cortical synaptophysin expression of up to 26.5% (mean 11%) of the controls. No correlation was found between synaptophysin expressivity and age either in AD or in the controls. Univariate analyses revealed only a very weak negative correlation between the density of beta A4-immunoreactive cortical plaques and the intensity of the synaptophysin staining, while in a multivariate analysis the plaque density did not show any impact on the latter. In HD a reduction of the synaptophysin immunoreactivity of the cortical neuropil was also found (mean 10.4%), with a predominance in the pyramidal layer of the neocortex. The same was true for PD (5.3%) and PD-D (8.2%). Our results support the view that loss of synapses in the cortical neuropil may be a significant factor for the development of organic dementia, while the amyloid pathology in AD is more likely a marker of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358515     DOI: 10.1159/000107299

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  31 in total

1.  Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

Authors:  M Buttini; M Orth; S Bellosta; H Akeefe; R E Pitas; T Wyss-Coray; L Mucke; R W Mahley
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

Review 2.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 3.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

4.  Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors.

Authors:  F Huang; M Buttini; T Wyss-Coray; L McConlogue; T Kodama; R E Pitas; L Mucke
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 5.  Effects of normal aging on prefrontal area 46 in the rhesus monkey.

Authors:  Jennifer Luebke; Helen Barbas; Alan Peters
Journal:  Brain Res Rev       Date:  2009-12-11

6.  Chronic oral estrogen affects memory and neurochemistry in middle-aged female mice.

Authors:  Stephanie M Fernandez; Karyn M Frick
Journal:  Behav Neurosci       Date:  2004-12       Impact factor: 1.912

7.  Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.

Authors:  S S Zhan; W Kamphorst; W E Van Nostrand; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.

Authors:  K Blennow; N Bogdanovic; I Alafuzoff; R Ekman; P Davidsson
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

9.  Regulation of posttranscriptional modification as a possible therapeutic approach for retinal neuroprotection.

Authors:  Yoko Ozawa; Toshihide Kurihara; Kazuo Tsubota; Hideyuki Okano
Journal:  J Ophthalmol       Date:  2010-11-07       Impact factor: 1.909

10.  Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.

Authors:  M Sasaki; Y Ozawa; T Kurihara; S Kubota; K Yuki; K Noda; S Kobayashi; S Ishida; K Tsubota
Journal:  Diabetologia       Date:  2010-02-17       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.